Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 104
12
Diseases
29
Unique genes
0.283
Avg. similarity score
Biventricular noncompaction cardiomyopathy
Most-connected disease (11 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Biventricular noncompaction cardiomyopathy
MYH7-related skeletal myopathy
Myosin storage myopathy
dilated cardiomyopathy 1S
Asymmetric septal hypertrophy
Scapuloperoneal myopathy
Camptocormia
Coronary stenosis
Ebstein anomaly
Multiminicore myopathy
Parieto-occipital craniosynostosis
Polymorphic ventricular tachycardia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Biventricular noncompaction cardiomyopathy | 11 | 11 | 1 |
| MYH7-related skeletal myopathy | 11 | 11 | 1 |
| Myosin storage myopathy | 11 | 11 | 1 |
| dilated cardiomyopathy 1S | 11 | 11 | 1 |
| Asymmetric septal hypertrophy | 5 | 5 | 4 |
| Scapuloperoneal myopathy | 5 | 5 | 2 |
| Camptocormia | 4 | 4 | 4 |
| Coronary stenosis | 4 | 4 | 16 |
| Ebstein anomaly | 4 | 4 | 2 |
| Multiminicore myopathy | 4 | 4 | 3 |
| Parieto-occipital craniosynostosis | 4 | 4 | 2 |
| Polymorphic ventricular tachycardia | 4 | 4 | 4 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MYH7 | 12 / 12 | Asymmetric septal hypertrophy, Biventricular noncompaction cardiomyopathy, Camptocormia, Coronary stenosis and 8 more |
| FHL1 | 2 / 12 | Asymmetric septal hypertrophy, Scapuloperoneal myopathy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Hypertrophic cardiomyopathy | KEGG | 6 / 99 | 25.1× | 1.10e-7 | 7.10e-6 ✓ sig. |
| Dilated cardiomyopathy | KEGG | 5 / 105 | 19.7× | 4.66e-6 | 1.80e-4 ✓ sig. |
| Cytoskeleton in muscle cells | KEGG | 6 / 232 | 10.7× | 1.59e-5 | 4.96e-4 ✓ sig. |
| Role of phospholipids in phagocytosis | Reactome | 2 / 21 | 39.4× | 1.15e-3 | 1.51e-2 ✓ sig. |
| Cardiac muscle contraction | KEGG | 3 / 87 | 14.3× | 1.17e-3 | 1.53e-2 ✓ sig. |
| cAMP signaling pathway | KEGG | 4 / 226 | 7.3× | 2.00e-3 | 2.28e-2 ✓ sig. |
| Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B) | Reactome | 1 / 1 | 414× | 2.41e-3 | 2.62e-2 ✓ sig. |
| Striated Muscle Contraction | Reactome | 2 / 36 | 23.0× | 3.37e-3 | 3.35e-2 ✓ sig. |
| Vascular smooth muscle contraction | KEGG | 3 / 134 | 9.3× | 4.01e-3 | 3.78e-2 ✓ sig. |
| DAG and IP3 signaling | Reactome | 1 / 2 | 207× | 4.82e-3 | 4.28e-2 ✓ sig. |
| Adrenergic signaling in cardiomyocytes | KEGG | 3 / 154 | 8.1× | 5.92e-3 | 4.89e-2 ✓ sig. |
| cGMP-PKG signaling pathway | KEGG | 3 / 166 | 7.5× | 7.28e-3 | 5.61e-2 |
| Ion homeostasis | Reactome | 2 / 54 | 15.3× | 7.45e-3 | 5.69e-2 |
| Histamine receptors | Reactome | 1 / 4 | 104× | 9.62e-3 | 6.71e-2 |
| NGF processing | Reactome | 1 / 4 | 104× | 9.62e-3 | 6.71e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cardiac muscle contraction | GO:0060048 | 6 / 43 | 89.9× | 4.71e-11 | 1.46e-8 ✓ sig. |
| striated muscle contraction | GO:0006941 | 4 / 24 | 107× | 4.86e-8 | 6.63e-6 ✓ sig. |
| positive regulation of heart rate | GO:0010460 | 4 / 25 | 103× | 5.78e-8 | 7.66e-6 ✓ sig. |
| regulation of heart rate | GO:0002027 | 4 / 39 | 66.1× | 3.70e-7 | 3.63e-5 ✓ sig. |
| cellular response to caffeine | GO:0071313 | 3 / 11 | 176× | 5.50e-7 | 5.07e-5 ✓ sig. |
| Purkinje myocyte to ventricular cardiac muscle cell signaling | GO:0086029 | 2 / 2 | 644× | 2.33e-6 | 1.62e-4 ✓ sig. |
| response to muscle stretch | GO:0035994 | 3 / 20 | 96.7× | 3.76e-6 | 2.39e-4 ✓ sig. |
| glomerular endothelium development | GO:0072011 | 2 / 5 | 258× | 2.32e-5 | 1.00e-3 ✓ sig. |
| regulation of atrial cardiac muscle cell membrane repolarization | GO:0060372 | 2 / 6 | 215× | 3.47e-5 | 1.37e-3 ✓ sig. |
| sarcomere organization | GO:0045214 | 3 / 43 | 45.0× | 3.98e-5 | 1.51e-3 ✓ sig. |
| positive regulation of cardiac muscle contraction | GO:0060452 | 2 / 9 | 143× | 8.32e-5 | 2.64e-3 ✓ sig. |
| gastric acid secretion | GO:0001696 | 2 / 9 | 143× | 8.32e-5 | 2.64e-3 ✓ sig. |
| mitochondrial DNA replication | GO:0006264 | 2 / 11 | 117× | 1.27e-4 | 3.61e-3 ✓ sig. |
| cellular response to epinephrine stimulus | GO:0071872 | 2 / 12 | 107× | 1.52e-4 | 4.14e-3 ✓ sig. |
| cardiac muscle hypertrophy | GO:0003300 | 2 / 13 | 99.1× | 1.79e-4 | 4.68e-3 ✓ sig. |